Bulls Charge Ahead: Sensex, Nifty Set for Higher Open; FirstCry, NTPC, JSW Steel, Paras Defence, Paytm, Glenmark Pharma in Limelight

Updated: May 26, 2025 09:05

Image Source: The Hans India

Indian equity markets are poised for a buoyant start this Monday, with benchmark indices Sensex and Nifty expected to open higher, building on last week’s rally. Early GIFT Nifty trends indicate a robust opening, mirroring positive cues from global markets and renewed investor optimism.

Key Highlights:

Market Momentum: Sensex and Nifty are set to extend gains after Friday’s strong rebound, where the Sensex jumped 769 points and Nifty closed above 24,850. Asian markets and U.S. futures are in the green, further fueling bullish sentiment.

NTPC in Focus: NTPC shares are in the spotlight after the company posted a stellar 22% year-on-year surge in consolidated Q4 net profit to ₹7,897 crore, propelled by higher operational efficiency and power generation. Revenue rose 3.2% to ₹49,834 crore, reinforcing NTPC’s leadership in the power sector.

JSW Steel: The steel major reported a 16% rise in Q4 net profit to ₹1,503 crore, supported by strong volumes and cost efficiencies, though topline growth was muted due to weak steel prices. Brokerages remain optimistic, citing new capacities and robust domestic demand.

Paras Defence: Shares of Paras Defence have surged over 50% in the past month, with Q4 profit at ₹19.7 crore and revenue at ₹112.3 crore, reflecting strong momentum in the defense sector.

FirstCry & Paytm: FirstCry (Brainbees Solutions) will announce its quarterly results today, while Paytm’s parent, One 97 Communications, received relief from the Supreme Court as proceedings on a major GST notice were stayed, lifting investor sentiment.

Glenmark Pharma & Others: Glenmark Pharma and other key stocks are also expected to see action as the market digests the latest earnings and sectoral cues.

With FIIs turning net buyers and domestic investors providing steady support, all eyes are on whether the indices can break out above key resistance levels and sustain the positive trend.

Sources: Moneycontrol, Business Today, Economic Times

Stay Ahead – Explore Now! Glenmark Pharma's US Unit to Launch Dextroamphetamine Saccharate Tablets, Bolstering CNS Portfolio